Healthcare & Pharmaceuticals Industry Press Releases

Published on April 13, 2021 - 12:00 GMT

Celularity Receives Orphan Drug Designation for Natural Killer Cell Therapy CYNK-001 in the Treatment of Malignant Gliomas

FLORHAM PARK, N.J., April 13, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on April 13, 2021 - 12:00 GMT

Clubhouse Media’s Influencer-Based Model and Las Vegas Content House Profiled in Top-25 Newspaper

LOS ANGELES, April 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS:CMGR) (“Clubhouse Media” or the “Company”), an influencer-based marketing and media firm with a vast aggregate global social media reach, is pleased to …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 13, 2021 - 12:00 GMT

Voltron Therapeutics, Inc. Announces COVID-19 and Pandemic Preparedness Presentation to Congressional Offices and Agencies, ...

NEW YORK, April 13, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that the Company presented to Congressional Offices and Agencies, including HHS, NIH, FDA and the DoD on Thursday April 8th. This follows dozens of recent one-on-one …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on April 13, 2021 - 12:00 GMT

Monumental Sports & Entertainment Announces Installation of Cutting-Edge UVC Sanitization Technology at D.C.’s Capital One Arena

Washington, DC, April 13, 2021 (GLOBE NEWSWIRE) -- To help increase protections against pathogens and viruses, Monumental Sports & Entertainment announced today that it has installed state-of-the-art air sanitizing ceiling troffers in key locations for …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 13, 2021 - 12:00 GMT

Acutus Medical Announces FDA Clearance of AcQCross™, a Full Suite of Universal Transseptal Crossing Devices

CARLSBAD, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the FDA clearance of the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on April 13, 2021 - 11:59 GMT

Skylight Health Announces Fourth Quarter and Full Year Fiscal 2020 Earnings Conference Call

TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that its financial results for the fourth …

Distribution channels:

Published on April 13, 2021 - 11:59 GMT

electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance

First-quarter 2021 revenue expected to be more than $1.1 million Net cash used for the first quarter 2021 of approximately $4.1 million ROCKAWAY, NJ, April 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic …

Distribution channels:

Published on April 13, 2021 - 11:55 GMT

Inovalon Announces Inaugural Sustainability Report

BOWIE, Md., April 13, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it has augmented its 2020 Annual Report with the provision of its inaugural …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 13, 2021 - 11:51 GMT

OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year

ROCHESTER, Mich. , April 13, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received the ranking of #277 by the Financial Times (FT) list of …

Distribution channels:

Published on April 13, 2021 - 11:45 GMT

BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven ...

PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO), and the University of California, San Diego (UC San Diego) today announced a partnership to translate research in genetically driven conditions into potential …

Distribution channels:

Published on April 13, 2021 - 11:42 GMT

BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven ...

PALO ALTO, Calif. and SACRAMENTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with the University of California, Davis (UC Davis), to advance research and the development of …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 13, 2021 - 11:40 GMT

BridgeBio Pharma, Inc. and Roswell Park Establish Collaboration to Translate Pioneering Research into Therapies for Genetically ...

PALO ALTO, Calif. and BUFFALO, N.Y., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with Roswell Park Comprehensive Cancer Center to advance the development of investigational therapeutics for …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 13, 2021 - 11:37 GMT

BridgeBio Pharma, Inc. and Oregon Health & Science University Establish Collaboration to Translate Pioneering Research into ...

PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with Oregon Health & Science University (OHSU) in Portland, Oregon, to advance research and the development of investigational …

Distribution channels:

Published on April 13, 2021 - 11:35 GMT

BridgeBio Pharma, Inc. and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers

TORRANCE, Calif. and PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) and The Lundquist Institute for Biomedical Innovation at the Harbor-UCLA Medical Center today announced a collaboration to translate research …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 13, 2021 - 11:32 GMT

BridgeBio Pharma, Inc. and GlycoNet Initiate Collaboration to Discover Potential Treatments for Genetic Diseases through Glycomics ...

PALO ALTO, Calif. and EDMONTON, Alberta, April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) and the Canadian Glycomics Network (GlycoNet), a pan-Canadian Network of Centres of Excellence, today announced a collaboration to translate …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...